Zai Lab Ltd financial data

Symbol
ZLAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4560 Jinke Road, Bldg. 1, 4 F, Pudong, Shanghai, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 381 % -52.2%
Quick Ratio 17.6 % -39%
Debt-to-equity 36.4 % +107%
Return On Equity -37 % -18.6%
Return On Assets -27.1 % -2.23%
Operating Margin -137 % +26.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 984M shares +1.58%
Entity Public Float 2.7B USD -15.6%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 982M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 982M shares +1.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 102M USD +47.7%
Revenue from Contract with Customer, Excluding Assessed Tax 355M USD +35%
Cost of Revenue 108M USD +35.6%
Research and Development Expense 264M USD +5.31%
Operating Income (Loss) -338M USD +0.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -271M USD +39.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -271M USD +10%
Earnings Per Share, Basic -0.27 USD/shares +12.9%
Earnings Per Share, Diluted -0.27 USD/shares +12.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 616M USD -21.9%
Accounts Receivable, after Allowance for Credit Loss, Current 50M USD +20.1%
Inventory, Net 39.5M USD -10.6%
Assets, Current 861M USD -10.3%
Property, Plant and Equipment, Net 50.8M USD -8.17%
Operating Lease, Right-of-Use Asset 12.8M USD -21.7%
Intangible Assets, Net (Excluding Goodwill) 51.7M USD +3195%
Assets 985M USD -5.59%
Accounts Payable, Current 121M USD +119%
Employee-related Liabilities, Current 24.1M USD -7.56%
Liabilities, Current 286M USD +129%
Operating Lease, Liability, Noncurrent 6.11M USD -37.7%
Other Liabilities, Noncurrent 325K USD 0%
Liabilities 318M USD +95.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 28.3M USD -41%
Retained Earnings (Accumulated Deficit) -2.37B USD -12.9%
Stockholders' Equity Attributable to Parent 668M USD -24.2%
Liabilities and Equity 985M USD -5.59%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -90.1M USD -30%
Net Cash Provided by (Used in) Financing Activities 47.5M USD
Net Cash Provided by (Used in) Investing Activities 3.29M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 989M shares +1.58%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.4M USD +69.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45K USD
Deferred Tax Assets, Valuation Allowance 358M USD +26%
Operating Lease, Liability 15.2M USD -25.7%
Depreciation 8.8M USD +8.64%
Payments to Acquire Property, Plant, and Equipment 974K USD -72.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -291M USD +0.69%
Lessee, Operating Lease, Liability, to be Paid 15.6M USD -26.6%
Property, Plant and Equipment, Gross 87.1M USD +5.12%
Operating Lease, Liability, Current 6.59M USD -4.37%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.14M USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.44M USD -1.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 460K USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.81M USD -60.5%
Deferred Tax Assets, Operating Loss Carryforwards 295M USD +22.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 822K USD -52.6%
Amortization of Intangible Assets 700K USD +250%
Depreciation, Depletion and Amortization 3.01M USD +13.4%
Deferred Tax Assets, Net of Valuation Allowance 2.83M USD -24.4%
Share-based Payment Arrangement, Expense 73.9M USD -1.13%
Interest Expense 113K USD